Clinical Trial

A Clinical Trial of Nemtabrutinib in Participants With Severe Kidney Disease (MK-1026-027)

Name: A Clinical Trial of Nemtabrutinib in Participants With Severe Kidney Disease (MK-1026-027) — clinical trial record (NCT07734610)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The purpose of this study is to learn what happens to nemtabrutinib in a person's body when given to participants with severe kidney disease and to healthy participants.

Trial Details

NCT Number	NCT07734610
Lead Sponsor	Merck Sharp & Dohme LLC
Conditions	Severe Renal Impairment, Healthy
Enrollment	20 participants
Start Date	2026-08-17
Primary Completion	2027-02-01 (estimated)
Study Completion	2027-02-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-29